Ventilation impairment of residents around a cement plant

Annals of Occupational and Environmental Medicine

Volumn 27, Issue 1, 2015, Pages

  Kim, Sul H ^a   Lee, Chul G ^a   Song, Han S ^a   Lee, Hyun S ^a   Jung, Min S ^a   Kim, Jae Y ^a   Park, Choong H ^b   Ahn, Seung C ^b   Yu, Seung D ^b  

^a Chosun University College of Medicine   (South Korea)

^b National Institute of Environmental Research   (South Korea)

Author keywords

Cement; Particulate; Pulmonary function test; Restrictive ventilation impairment

Indexed keywords

ADULT; AGED; AIR POLLUTION; ARTICLE; CEMENT INDUSTRY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUST EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HEALTH SURVEY; HUMAN; KOREA; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SPIROMETRY; VENTILATION IMPAIRMENT;

EID: 84979199773     PISSN: None     EISSN: 20524374     Source Type: Journal    
DOI: 10.1186/s40557-014-0048-6     Document Type: Article

References (40)

1. Leem JH, Cho JH, Lee EC, Kim JH, Lee DH, Lee SJ, Lee JY, Kim HC. Clusters of pneumoconiosis among residents near cement factories. Korean J Occup Environ Med 2010, 22(2):140-145. Korean.
2. Van Oss H, Padovani AC. Cement manufacture and the environment: part I: chemistry and technology. J Ind Ecol 2002, 6(1):89-105. 10.1162/108819802320971650.
3. Meo SA. Health hazards of cement dust. Saudi Med J 2004, 25(9):1153-1159. 15448758.
4. Van Oss H, Padovani AC. Cement manufacture and the environment: part II: environmental challenges and opportunities. J Ind Ecol 2003, 7(1):93-126. 10.1162/108819803766729212.
5. Abrons HL, Petersen MR, Sanderson WT, Engelberg AL, Harber P. Chest radiography in Portland cement workers. J Occup Environ Med 1997, 39(11):1047-1054. 10.1097/00043764-199711000-00005, 9424275.
6. Smailyte G, Kurtinaitis J, Andersen A. Mortality and cancer incidence among Lithuanian cement producing workers. Occup Environ Med 2004, 61(6):529-534. 10.1136/oem.2003.009936, 15150393.
7. Dietz A, Ramroth H, Urban T, Ahrens W, Becher H. Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case-control study. Int J Cancer 2004, 108(6):907-911. 10.1002/ijc.11658, 14712496.
8. Goon ATJ, Goh CL. Epidemiology of occupational skin disease in Singapore 1989-1998. Contact Dermatitis 2000, 43(3):133-136. 10.1034/j.1600-0536.2000.043003133.x, 10985628.
9. Spoo J, Elsner P. Cement burns: a review 1960-2000. Contact Dermatitis 2001, 45(2):68-71. 10.1034/j.1600-0536.2001.045002068.x, 11553114.
10. Wang B, Wu J-D, Sheu S-C, Shih T-S, Chang H-Y, Guo Y-L, Wang Y-J, Chou T-C. Occupational hand dermatitis among cement workers in Taiwan. J Formos Med Assoc 2011, 110(12):775-779. 10.1016/j.jfma.2011.11.008, 22248832.
11. Al-Neaimi Y, Gomes J, Lloyd O. Respiratory illnesses and ventilatory function among workers at a cement factory in a rapidly developing country. Occup Med 2001, 51(6):367-373. 10.1093/occmed/51.6.367.
12. Merenu I, Mojiminiyi F, Njoku C, Ibrahim M. The effect of chronic cement dust exposure on lung function of cement factory workers in sokoto, Nigeria. Afr J Biomed Res 2007, 10(2):139-143.
13. Mirzaee R, Kebriaei A, Hashemi S, Sadeghi M, Shahrakipour M. Effects of exposure to Portland cement dust on lung function in Portland cement factory workers in Khash, Iran. IJEHSE 2008, 5(3):201-206.
14. Poornajaf A, Kakooei H, Hosseini M, Ferasati F, Kakaei H. The effect of cement dust on the lung function in a cement factory, Iran. IJOH 2010, 2(2):4-8.
15. Zeleke ZK, Moen BE, Bratveit M. Cement dust exposure and acute lung function: a cross shift study. BMC Pulm Med 2010, 10:19. 10.1186/1471-2466-10-19, 20398255.
16. Nordby K-C, Fell AKM, Notø H, Eduard W, Skogstad M, Thomassen Y, Bergamaschi A, Kongerud J, Kjuus H. Exposure to thoracic dust, airway symptoms and lung function in cement production workers. Eur Respir J 2011, 38(6):1278-1286. 10.1183/09031936.00007711, 21659410.
17. Ahmed HO, Abdullah AA. Dust exposure and respiratory symptoms among cement factory workers in the United Arab Emirates. Ind Health 2012, 50(3):214-222. 10.2486/indhealth. MS1320, 22453209.
18. Kumagai S, Kurumatani N. Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents. Am J Ind Med 2009, 52(10):790-798. 10.1002/ajim.20743, 19728322.
19. Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy). Int Arch Occup Environ Health 2009, 82(4):489-497. 10.1007/s00420-008-0358-5, 18810484.
20. Gbadebo A, Bankole O. Analysis of potentially toxic metals in airborne cement dust around Sagamu, southwestern Nigeria. J Appl Sci 2007, 7(1):35-40. 10.3923/jas.2007.35.40.
21. Cha KT, Oh SS, Yoon JH, Lee KH, Kim SK, Cha BS, Kim SH, Eom AY, Koh SB. Adverse health outcomes in residents exposed to cement dust. J Toxicol Environ Health Sci 2011, 3(4):239-244. 10.1007/s13530-011-0101-6.
22. The technical guideline on pulmonary function test and interpretation KOSHA GUIDE 2013, Korean.
23. FORCE AET, Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CM, Gustafsson P. General considerations for lung function testing. Eur Respir J 2005, 26(1):153-161. 10.1183/09031936.05.00034505.
24. Townsend MC. Spirometry in the occupational health setting-2011 update. J Occup Environ Med 2011, 53(5):569-584. 10.1097/JOM.0b013e31821aa964, 21555926.
25. FORCE AET, Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van Der Grinten C, Gustafsson P. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338. 10.1183/09031936.05.00034805.
26. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013, 187(4):347-365. 10.1164/rccm.201204-0596PP, 22878278.
27. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis (Seoul) 2005, 58(3):230-242.
28. Dockery DW. Health effects of particulate air pollution. Ann Epidemiol 2009, 19(4):257-263. 10.1016/j.annepidem.2009.01.018, 19344865.
29. Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:233-243. 10.2147/COPD.S5098, 19554194.
30. Burnett RT, Pope CA, Ezzati M, Olives C, Lim SS, Mehta S, Shin HH, Singh G, Hubbell B, Brauer M, Anderson HR, Smith KR, Balmes JR, Bruce NG, Kan H, Laden F, Pruss-Ustun A, Turner MC, Gapstur SM, Diver WR, Cohen A. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect 2014, 122(4):397-403. 24518036.
31. Khang Y-H, Cho H-J. Socioeconomic inequality in cigarette smoking: trends by gender, age, and socioeconomic position in South Korea, 1989-2003. Prev Med 2006, 42(6):415-422. 10.1016/j.ypmed.2006.02.010, 16580714.
32. Booker R. Best practice in the use of spirometry. Nurs Stand 2005, 19(48):49-54. 10.7748/ns2005.08.19.48.49.c3930, 16117269.
33. Ling SH, McDonough JE, Gosselink JV, Elliott WM, Hayashi S, Hogg JC, van Eeden SF. Patterns of retention of particulate matter in lung tissues of patients with COPD. Chest 2011, 140(6):1540-1549. 10.1378/chest.10-2281, 21659433.
34. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res 2013, 14:103. 10.1186/1465-9921-14-103, 24107140.
35. Tan WC, Vollmer WM, Lamprecht B, Mannino DM, Jithoo A, Nizankowska-Mogilnicka E, Mejza F, Gislason T, Burney PG, Buist AS. Worldwide patterns of bronchodilator responsiveness: results from the burden of obstructive lung disease study. Thorax 2012, 67(8):718-726. 10.1136/thoraxjnl-2011-201445, 22544896.
36. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. The Lancet 2007, 370(9589):765-773. 10.1016/S0140-6736(07)61380-4.
37. FORCE AET, Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R, Coates A, Van der Grinten C, Gustafsson P, Hankinson J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968. 10.1183/09031936.05.00035205.
38. Esmaeil N, Gharagozloo M, Rezaei A, Grunig G. Dust events, pulmonary diseases and immune system. Am J Clin Exp Immunol 2014, 3(1):20. 24660118.
39. FORCE AET, Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten C. Standardisation of the measurement of lung volumes. Eur Respir J 2005, 26(3):511-522. 10.1183/09031936.05.00035005.
40. Sterk P. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J 2004, 23(4):497-498. 10.1183/09031936.04.00017104, 15083741.